Skip to content

GLOMERULUS

Active
Private limited companyfounded 2021active for 5 yearsVoorstadstraat(KOM) 64, 7780 Comines-Warneton, BelgiumKBO/BCE: BE 0763.851.541
Summary

GLOMERULUS has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,000 and a net result of €171,893. Equity remains stable across the filed financial years (±0% per year). Its solvency ranks better than 8% of 20,589 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€178,638total assets 2025
Equity
€5,000
Profit
€171,893
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts 25 days early0 of 1 deed read
Why 91raises riskEquity €5,000 (2.8% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €178,638Figures for financial year 2025 (filed 06-07-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 32% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 28=
equity 2.8% of total assets
Liquidity 17-33
short-term debt 97.2% · cash 13.4%
Profitability 100=
return on assets 96.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,109 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026highest value
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 8% on solvency, 2% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €178,638
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €5,000 (2.8% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 06-07-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 20589 sector peers (2025).
NBB · sector comparison
Position among 20589 sector peers
Solvency
better than 8%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
25 days early
2024
24 days early
2023
26 days early
2022
20 days early
2021
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 22 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2021 to 2025net €183,909 ▲28.3%

Financials · financial year 2025, micro format

Equity
€5,000=
2024 · €5,000
Total assets
€178,638▼ 6.7%
2024 · €191,438
Net result
€171,893▼ 6.5%
2024 · €183,909
Working capital
€3,232▼ 35.1%
2024 · €4,980
Trend over the years

2021 to 2025, 5 financial years

The operating result falls in 2025; 2025 is 5% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€227,380 2025 Net result€171,893 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20212022202320242025
Operating result€86,842-€115,841▲ 33.4%€185,521▲ 60.2%€240,269▲ 29.5%€227,380▼ 5.4%
Net result€67,459within the sector's middle half-€89,683within the sector's middle half▲ 32.9%€143,307above the sector's middle half▲ 59.8%€183,909above the sector's middle half▲ 28.3%€171,893above the sector's middle half▼ 6.5%
Equity€5,000below the sector's middle half-€5,000below the sector's middle half=€5,000below the sector's middle half=€5,000below the sector's middle half=€5,000below the sector's middle half=
Total assets€125,154below the sector's middle half-€138,632below the sector's middle half▲ 10.8%€189,029within the sector's middle half▲ 36.4%€191,438within the sector's middle half▲ 1.3%€178,638within the sector's middle half▼ 6.7%
Debt€120,154-€133,632▲ 11.2%€184,029▲ 37.7%€186,438▲ 1.3%€173,638▼ 6.9%
Working capital-€12,294below the sector's middle half--€4,601below the sector's middle half▲ 62.6%€3,542below the sector's middle half€4,980below the sector's middle half▲ 40.6%€3,232below the sector's middle half▼ 35.1%
Solvency4.0%below the sector's middle half-3.6%below the sector's middle half▼ 0.4pp2.6%below the sector's middle half▼ 1.0pp2.6%below the sector's middle half=2.8%below the sector's middle half▲ 0.2pp
Current ratio0.90below the sector's middle half-0.97below the sector's middle half▲ 0.071.02below the sector's middle half▲ 0.051.03below the sector's middle half▲ 0.011.02below the sector's middle half▼ 0.01
Return on assets (ROA)53.9%above the sector's middle half-64.7%above the sector's middle half▲ 10.8pp75.8%above the sector's middle half▲ 11.1pp96.1%above the sector's middle half▲ 20.3pp96.2%above the sector's middle half▲ 0.2pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €178,638
Fixed assets €1,768 ▲ 8,745%
Current assets €176,870 ▼ 7.6%
Equity and liabilities €178,638
Equity €5,000 =
Debt €173,638 ▼ 6.9%
Debt's share of the balance-sheet total falls from 97.4% to 97.2%. Debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€227,714▼
2024 · €241,706
Cash flow
€172,227▼
2024 · €185,347
Debt to equity
34.73▼
2024 · 37.29
Interest coverage
61.12▼
2024 · over 100
Debt ≤ 1 year
€173,638▼
2024 · €186,438
Income taxes
€58,430▼
2024 · €62,650
A ratio outside any meaningful range has been withheld (balance sheet total €178,638, equity €5,000).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,153 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96.1% are still going.

  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.7% went bankrupt
2.2% stopped otherwise
96.1% still going

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,153 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€191,438€178,638▼
Fixed assets21/28€20€1,768▲
Tangible fixed assets22/27€20€1,768▲
Furniture and vehicles24€20€1,768▲
Current assets29/58€191,418€176,870▼
Amounts receivable within one year40/41€90,069€89,017▼
Trade receivables40€19,196€18,538▼
Other amounts receivable41€70,872€70,479▼
Current investments50/53€19,958€63,600▲
Cash at bank and in hand54/58€80,906€23,865▼
Deferred charges and accrued income490/1€486€389▼
Equity and liabilities
Total equity and liabilities10/49€191,438€178,638▼
Equity10/15€5,000€5,000=
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€186,438€173,638▼
Amounts payable within one year42/48€186,438€173,638▼
Trade debts44€997€0▼
Suppliers440/4€997€0▼
Taxes, remuneration and social security45€29,118€27,529▼
Taxes450/3€29,118€27,529▼
Other amounts payable47/48€156,323€146,109▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,438€334▼
Other operating charges640/8€740€780▲
Gross operating margin9900€242,446€228,494▼
Operating profit (loss)9901€240,269€227,380▼
Financial income75/76B€6,879€6,669▼
Recurring financial income75€6,879€6,669▼
Financial charges65/66B€588€3,726▲
Recurring financial charges65€588€3,726▲
Profit (loss) for the period before taxes9903€246,559€230,323▼
Income taxes67/77€62,650€58,430▼
Profit (loss) for the period9904€183,909€171,893▼
Profit (loss) for the period to be appropriated9905€183,909€171,893▼
Appropriation of the result
Profit (loss) to be appropriated9906€183,909€171,893▼
Profit to be distributed694/7€183,909€171,893▼
Return on contributions (dividend)694€183,909€171,893▼

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,706€8,122€8,143€1,438€334▼ 76.8%
Other operating charges640/8€1,421€653€714€740€780▲ 5.4%
Gross operating margin9900€94,969€124,616€194,378€242,446€228,494▼ 5.8%
Operating profit (loss)9901€86,842€115,841€185,521€240,269€227,380▼ 5.4%
Financial income75/76B€0€138€2,391€6,879€6,669▼ 3.0%
Recurring financial income75€0€138€2,391€6,879€6,669▼ 3.0%
Financial charges65/66B€899€934€444€588€3,726▲ 533%
Recurring financial charges65€899€934€444€588€3,726▲ 533%
Profit (loss) for the period before taxes9903€85,943€115,045€187,467€246,559€230,323▼ 6.6%
Income taxes67/77€18,484€25,362€44,160€62,650€58,430▼ 6.7%
Profit (loss) for the period9904€67,459€89,683€143,307€183,909€171,893▼ 6.5%
Profit (loss) for the period to be appropriated9905€67,459€89,683€143,307€183,909€171,893▼ 6.5%
Line20212022202320242025Change
Assets
Total assets20/58€125,154€138,632€189,029€191,438€178,638▼ 6.7%
Fixed assets21/28€17,294€9,601€1,458€20€1,768▲ 8,745%
Tangible fixed assets22/27€17,294€9,601€1,458€20€1,768▲ 8,745%
Furniture and vehicles24€17,294€9,601€1,458€20€1,768▲ 8,745%
Current assets29/58€107,860€129,031€187,572€191,418€176,870▼ 7.6%
Amounts receivable within one year40/41€12,200€15,110€115,314€90,069€89,017▼ 1.2%
Trade receivables40€12,200€11,140€20,877€19,196€18,538▼ 3.4%
Other amounts receivable41-€3,970€94,437€70,872€70,479▼ 0.6%
Current investments50/53---€19,958€63,600▲ 219%
Cash at bank and in hand54/58€95,238€113,451€71,604€80,906€23,865▼ 70.5%
Deferred charges and accrued income490/1€423€470€654€486€389▼ 20.1%
Equity and liabilities
Total equity and liabilities10/49€125,154€138,632€189,029€191,438€178,638▼ 6.7%
Equity10/15€5,000€5,000€5,000€5,000€5,000=
Contributions10/11€5,000€5,000€5,000€5,000€5,000=
Profit (loss) carried forward14€0€0€0€0€0-
Amounts payable17/49€120,154€133,632€184,029€186,438€173,638▼ 6.9%
Amounts payable within one year42/48€120,154€133,632€184,029€186,438€173,638▼ 6.9%
Trade debts44€2,413€0-€997€0▼ 100%
Suppliers440/4€2,413€0-€997€0▼ 100%
Taxes, remuneration and social security45€38,020€57,402€62,218€29,118€27,529▼ 5.5%
Taxes450/3€38,020€57,402€62,218€29,118€27,529▼ 5.5%
Other amounts payable47/48€79,722€76,230€121,811€156,323€146,109▼ 6.5%
Line20212022202320242025Change
Profit (loss) for the period9904€67,459€89,683€143,307€183,909€171,893▼ 6.5%
+ Depreciation and write-downs630€6,706€8,122€8,143€1,438€334▼ 76.8%
Operating cash flow (approximation)€74,165€97,805€151,450€185,347€172,227▼ 7.1%
Investment in fixed assets (approximation)--€429€0€0-€2,082-
Change in cash-€18,214-€41,848€9,302-€57,040-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (5)
Financial year Type Filed Reference
31-12-2025 micro format 06-07-2026 2026-00254980
31-12-2024 micro format 07-07-2025 2025-00235894
31-12-2023 micro format 05-07-2024 2024-00212924
31-12-2022 micro format 11-07-2023 2023-00227328
31-12-2021 micro format 15-07-2022 2022-20188167

Similar companies · same sector, comparable size

Of the 16,584 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,111. 1,587 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 19 February 2021, GLOMERULUS was incorporated as a private limited company.1 Total assets went from €125,154 in 2021 to €178,638 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
06-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
07-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2021 to 2025net €183,909 ▲28.3%
Operating result €240,269, net result €183,909, both a record.
05-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
11-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
15-07
NBB filing Annual accounts filed
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded19-02-2021
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0763851541
Registered 01-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 22 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

9845002BB8BC08R4H059
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Comines-Warneton · 1 establishment unit since 2021
registered office establishment The establishment unit on the map
Ground area
378 m²
Building footprint
44 m²
Building volume
480 m³
Parcel 54002C0557/00B000, Wallonia · tallest building 13.3 m. Linked by address, not a title deed.
1 establishment unit
GLOMERULUS
Voorstadstraat(KOM) 64, 7780 Comines-WarnetonSpecialist medical practice
since 2021unit no. 2.316.705.339
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
54002C0557/00B000 Wallonia 378 m² 1 · 44 m² 13.3 m · 4
How the parcels are linked
Good to know
The parcel matches the address exactly.